← Back to Search

Prostaglandin

15-methyl prostaglandin F2α for Postpartum Hemorrhage

Phase 4
Waitlist Available
Led By Naida M Cole, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within the first 24 hours after delivery of the fetus
Awards & highlights

Study Summary

This study is evaluating whether a medication may help reduce bleeding after childbirth.

Eligible Conditions
  • Postpartum Hemorrhage
  • Uterine Atony

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 5 minutes following administration of the first study drug
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 5 minutes following administration of the first study drug for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Additional Intervention
Additional Uterotonic
Hematocrit Drop
+5 more

Trial Design

2Treatment groups
Active Control
Group I: 15-methyl prostaglandin F2αActive Control2 Interventions
IM Carboprost followed by Methylergonovine if needed.
Group II: Methylergonovine MaleateActive Control2 Interventions
IM Methylergonovine followed by Carboprost if needed.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,614 Previous Clinical Trials
11,470,735 Total Patients Enrolled
4 Trials studying Postpartum Hemorrhage
167 Patients Enrolled for Postpartum Hemorrhage
Naida M Cole, MDPrincipal InvestigatorBrigham and Women's Hospital, 75 Francis Street, Boston MA 02115
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Postpartum Hemorrhage
100 Patients Enrolled for Postpartum Hemorrhage

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
Naida Margaret Cole 2019. "Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03584854.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top